Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

3

Number of overlapping holdings

33.3%

% of PSIL's 28 holdings also in IBRN

7.9%

% of IBRN's 52 holdings also in PSIL

Overlap by Weight
Sector Drift (PSIL minus IBRN)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in PSIL
Weight
in IBRN
Overlap
NEUROCRINE BIOSCIENCES INC 4.6% 4.7% 4.6%
INTRA-CELLULAR THERAPIES INC 4.5% 4.8% 4.5%
ALKERMES PLC 6.3% 3.8% 3.8%

Position Highlights (Non-Overlapping Exposures)
PSIL Overweight Relative to IBRN
ATAI LIFE SCIENCES N.V. 6.4%
INCANNEX HEALTHCARE INC. 5.2%
SAGE THERAPEUTICS INC 4.3%
ALKERMES PLC 2.5%
RELMADA THERAPEUTICS INC 1.3%
NUMINUS WELLNESS INC 1.2%
NEURONETICS, INC. 0.3%
NEUROCRINE BIOSCIENCES INC -0.1%
IDORSIA LTD. -0.2%
ELIEM THERAPEUTICS, INC. -0.2%
PSIL Underweight Relative to IBRN
SK BIOPHARMACEUTICALS CO., LTD. -4.6%
ARGENX SE ADR -4.5%
SUPERNUS PHARMACEUTICALS INC -4.3%
ACADIA PHARMACEUTICALS INC -4.2%
CATALYST PHARMACEUTICAL PART -4.2%
SAREPTA THERAPEUTICS INC -4.1%
BIOGEN IDEC INC -4.0%
SCHOLAR ROCK HOLDING CORP. -3.9%
PTC THERAPEUTICS INC -3.9%
INTEGRA LIFESCIENCES HOLDING -3.3%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY